ArticleBreast cancer research : BCR2012
Targeting triple-negative breast cancer cells with the histone deacetylase inhibitor panobinostat.
Chandra R Tate et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
137 papers cite itlatest 60 shown
this paperpooled ittrialcites it